Skip to main content

Should we screen for Abdominal Aortic Aneurysms?


Abdominal Aortic Aneurysms (AAA) pose one of the most interesting and difficult of dilemmas about disease screening. AAAs are dilitations of the aorta that are prone to rupture. AAA ruptures are catastrophic, and usually lethal (about 80% mortality). AAAs are pretty much a Geriatric disease, with almost all ruptures occurring after the age of 65. AAAs are much more common in men than women. (and most ruptures in women occur after the age of 80). There is a very strong association with smoking---those who ever or currently smoked are at least 3 times higher risk than never smokers.

Since repairing a AAA can prevent rupture, on the surface, this seems like a great disease for sceening. The problem is that surgical repair is a major operation, with substantial morbidity. About 5% of patients will not survive surgery. One way to think of this is as follows:

Among patients with AAAs, the patients who will benefit from surgery are those who will eventually have a rupture. However, all patients who will just live with the AAA, and eventually die of something else will be harmed by surgery, and sometimes this harm will be substantial. Obviously, there is no certain way to know in advance which group the patient sitting in front of you will end up in.

In 2002, a large RCT in the UK (Multicentre Aneurysm Screening Study--MASS) was published that supported screening 65-75 year old men for AAA. The investigators recently published the 10 year follow-up of MASS that further clarifies the role of AAA screening. This clever study randomized over 60,000 men 65-75 years old to two groups: One group received an invitation to receive a screening abdominal ultrasound (US). The other group got usual care. 80% of those invited attended the screening. If no AAA was detected, no further intervention was done. If a AAA between 3.0 to 4.4 cm was detected, the US was repeated yearly. If a AAA of 4.5-5.4 cm was detected (either initially, or on follow-up), the US was repeated every 3 months. If a AAA of 5.5 cm or greater was detected, the subject was referred for surgery. About 5% of subjects had a AAA detected on initial screening.

The primary outcome was a AAA related death, determined primarily with death certificates. A subject who died within 30 days of AAA surgery was also classified as having a AAA related death.

Over 10 years, about 1.6% of subjects in the screening group had elective surgery. The mortality rate from the AAA surgery was about 4%. Including these post-op deaths, approximately 0.5% of patients in the screening group died of AAA. In the control group, about 0.7% of subjects had elective surgery for AAA. About 0.9% of control subjects died of AAA. The cost analysis estimates that the screening program cost 7600 Pounds ($12,300) per year of life saved.

Another way to look at these results: For every 200 patients screened, one AAA death will be prevented, and two additional patients will have AAA surgery.

When we discussed this article at the UCSF Division of Geriatrics journal club this week, we debated whether this screening program should be routinely adopted in the US. Our group was split (5 in favor, 6 opposed). Those opposed noted that the improvement in AAA mortality might not necessarily translate into a benefit in terms of all cause mortality. They also felt that classifying 30 day post-surgical deaths as AAA deaths did not fully account for the downsides of the extra surgeries. Several noted that it is common for older patients to do poorly after major surgery, and some will have declines in functional status. These quality of life impacts may be substantial, and may causes long term decreases in survival.

Those in favor of screening, felt the survival benefit was substantial, and likely to outweigh the downsides of surgery. Because AAA rupture is so lethal, they felt it was unlikely this degree of AAA mortalty reduction would not translate to an all cause mortality reduction. It was also noted that a study powered to show an effect on all cause mortality would be impossibly large, and that demanding such evidence before we act sets the evidence bar unreasonably high.

Of note, in part based on the earlier results from MASS, the US Preventive Disease Task Force does recommend a one time screening ultrasound in men age 65-75 years who are current or past smokers. This is similar to the MASS protocol, except that the roughly 30% of men who never smoked would not be screened. The guideline and evidence report can be found on the Annals of Internal Medicine website.

Comments

Anonymous said…
Ola, what's up amigos? :)
Hope to get any help from you if I will have any quesitons.
Thanks and good luck everyone! ;)
Anonymous said…
Hi Folks!

I wanted to share with you a wonderful site I just came across teaching [url=http://www.kravmagabootcamp.com][b]Krav Maga[/b][/url] For All Levels If you guys have seen the Tv Show called Fight Quest you would have seen their chief instructor Ran Nakash there featured on their [url=http://www.kravmagabootcamp.com][b]Krav Maga[/b][/url] episode. Anyways, let me know what you think. Is training via the internet something you would do?


Holla

Joe
Dominador said…
who would have thought blogging will reach so far that it could reach all the informations to us,i admire the concept and solely the talent which is put in here.Regards.




Thanks,
Dom
plastic surgery advice

Popular posts from this blog

Lost in Translation: Google’s Translation of Palliative Care to ‘Do-Nothing Care’

by: Cynthia X. Pan, MD, FACP, AGSF (@Cxpan5X)

My colleagues often ask me: “Why are Chinese patients so resistant to hospice and palliative care?” “Why are they so unrealistic?” “Don’t they understand that death is part of life?” “Is it true that with Chinese patients you cannot discuss advance directives?”

As a Chinese speaking geriatrician and palliative care physician practicing in Flushing, NY, I have cared for countless Chinese patients with serious illnesses or at end of life.  Invariably, when Chinese patients or families see me, they ask me if I speak Chinese. When I reply “I do” in Mandarin, the relief and instant trust I see on their faces make my day meaningful and worthwhile.

At my hospital, the patient population is about 30% Asian, with the majority of these being Chinese. Most of these patients require language interpretation.  It becomes an interesting challenge and opportunity, as we often need to discuss advance directives, goals of care, and end of life care options…

Elderhood: Podcast with Louise Aronson

In this week's podcast we talk with Louise Aronson MD, MFA, Professor of Geriatrics at UCSF about her new book Elderhood, available for purchase now for delivery on the release date June 11th.

We are one of the first to interview Louise, as she has interviews scheduled with other lesser media outlets to follow (CBS This Morning and Fresh Air with Terry...somebody).

This book is tremendously rich, covering a history of aging/geriatrics, Louise's own journey as a geriatrician facing burnout, aging and death of family of Louise's members, insightful stories of patients, and more.

We focus therefore on the 3 main things we think our listeners and readers will be interested in.

First - why the word "Elder" and "Elderhood" when JAGS/AGS and others recently decided that the preferred terminology was "older adult"?

Second - Robert Butler coined the term ageism in 1969 - where do we see ageism in contemporary writing/thinking?  We focus on Louise's…

Psychedelics: Podcast with Ira Byock

In this week's podcast, we talk with Dr. Ira Byock, a leading palliative care physician, author, and public advocate for improving care through the end of life.

Ira Byock wrote a provocative and compelling paper in the Journal of Pain and Symptom Management titled, "Taking Psychedelics Seriously."

In this podcast we challenge Ira Byock about the use of psychedelics for patients with serious and life-limiting illness.   Guest host Josh Biddle (UCSF Palliative care fellow) asks, "Should clinicians who prescribe psychedelics try them first to understand what their patient's are going through?" The answer is "yes" -- read or listen on for more!

While you're reading, I'll just go over and lick this toad.

-@AlexSmithMD





You can also find us on Youtube!



Listen to GeriPal Podcasts on:
iTunes Google Play MusicSoundcloudStitcher
Transcript
Eric: Welcome to the GeriPal Podcast. This is Eric Widera.

Alex: This is Alex Smith.

Eric: Alex, I spy someone in our …